DUBLIN and PALO ALTO, Calif. - June 7, 2019 - Medtronic plc (MDT), the global leader in medical technology, services and solutions, and Tidepool, a 501(c)(3) nonprofit organization dedicated to making ...

As recently as a year-and-a-half ago, the chief executive of diabetes tech nonprofit Tidepool wouldn't have predicted a collaboration with Medtronic, he told MedTech Dive in an interview. "We are all ...

Loop is a DIY automated insulin delivery system with more customization and features than FDA-approved systems on the market. Justin Eastzer is a CNET Perspectives Contributor and former CNET host.

Medtronic is teaming up with the diabetes data nonprofit outfit Tidepool to create a new, interoperable version of its MiniMed insulin pump—and in return, the medtech giant will help Tidepool work to ...

The US Food and Drug Administration (FDA) has cleared the Tidepool Loop, a mobile application for use with compatible continuous glucose monitors (CGMs) and insulin pumps to enable automated insulin ...

Nonprofit diabetes management startup Tidepool received 510(k) clearance for its Tidepool Loop, an automated insulin dosing app that can enable insulin delivery from a compatible Apple Watch. The app ...

The 501(c)3 non-profit Tidepool, which seeks to empower the next generation of innovations in diabetes management, has announced that the US Food and Drug Administration (FDA) has cleared Tidepool ...

More than two years after submitting it for FDA review, Tidepool has scored the agency’s clearance for a smartphone app that allows people with Type 1 diabetes to build their own closed-loop ...

Tidepool’s automated insulin dosing app has been approved by the US Food and Drug Administration (FDA) to help those who are six years and older manage their type 1 diabetes. Tidepool is a nonprofit ...

Deka Research & Development has received 510(k) clearance for the Twiist automated insulin delivery (AID) system, the company’s partner Sequel Med Tech said Monday. Sequel, which will sell the system, ...